4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-025503
PRESIDENT AND CEO sold 924 shares at $30.00 ($27,723)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kintz Samuel · PRESIDENT AND CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-18 | Sale : show line 1 in the form 10b5-1 | −924 | $30.00 | $27,723 | 1,002,892 | I |
| Open-market sales · 924 sh · avg $30.00 · $27,723 | ||||||
Loading xslF345X05/form4-10222024_081007.xml…